ArticleHuman vaccines & immunotherapeutics2022

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report.

YunYi Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.